| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.0M | -49.9% |
| R&D Expense | $108.5M | +18.1% |
| SG&A Expense | $27.8M | -8.2% |
| Operating Income | -$121.5M | -38.8% |
| Income Tax | $0 | — |
| Net Income | -$118.5M | -38.7% |
| EPS (Basic) | -$2.19 | -37.7% |
| EPS (Diluted) | -$2.19 | -37.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.8M | -18.8% |
| Accounts Receivable | $2.8M | -15.2% |
| Inventory | $2.8M | +18.4% |
| Current Assets | $116.2M | -31.2% |
| Total Assets | $125.8M | -30.9% |
| Current Liabilities | $25.6M | +9.1% |
| Total Liabilities | $68.8M | +193.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$92.1M | -17.0% |
| Capital Expenditures | $2.4M | +5423.3% |
| Investing Cash Flow | $43.5M | -66.2% |
| Financing Cash Flow | $38.2M | — |
| Free Cash Flow | -$94.5M | -19.9% |
| Stockholders' Equity |
| $57.1M |
| -64.0% |